Clinical Trial Update: Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of a combination including ketoconazole, hydrocortisone, and GM-CSF in progressive prostate cancer after hormone therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Ketoconazole, Hydrocortisone, and GM-CSF combination

Snippet

Sponsor: University of California, San Francisco | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED